• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Hypertrophic cardiomyopathy (HCM) is a relatively common genetic heart disease
encumbered throughout much of its almost 60-year history by a large measure of …

Kardiomiopatie definiuje się jako strukturalne oraz funkcjonalne nieprawidłowości mięśnia
komór, które nie wynikają z niedokrwienia na skutek choroby wieńcowej czy …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted through January 2011. Searches were limited to …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted through January 2011. Searches were limited to …

Background There is little information regarding long-term mortality comparing the 2 most
common procedures for septal reduction for obstructive hypertrophic cardiomyopathy …

Objectives: The aim of this meta-analysis was to compare long-term outcomes after
myectomy and alcohol septal ablation (ASA) in patients with hypertrophic cardiomyopathy …

Objectives: The purpose of this study was to perform a systematic review and meta-analysis
of comparative studies to compare outcomes of septal ablation (SA) with septal myectomy …

Percutaneous and surgical therapies for septal reduction for hypertrophic cardiomyopathy
have been going head‐to‐head for the past 20 years with similar outcomes and mortality …

Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …